Emergent BioSolutions | Koszty Sprzedaży



Cost Of Sales Zmiana Data
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
ALKERMES USD 49.2M 12.92M 2025-03
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
Amarin USD 16.89M 18.51M 2025-03
ANI Pharmaceuticals USD 73.04M 7.24M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Exact Sciences USD 206.24M 77.89M 2025-03
Exelixis USD 19.17M 793K 2025-04
Glaxosmithkline GBP 2.52B 199M 2024-12
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Lonza CHF 2.47B 532M 2024-12
Merck USD 2.76B 944M 2025-03
Moderna USD 90M 456M 2025-03
Myriad Genetics USD 61.7M 2M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Pacira USD 34.31M 5.58M 2025-03
Pfizer USD 2.59B 3.06B 2025-03
PTC Therapeutics USD 12.86M 3.42M 2025-03
Sanofi EUR 2.89B 618M 2025-03
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
United Therapeutics USD 277.5M 201.6M 2025-03



Emergent BioSolutions Koszty Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.